PC
AUPH icon

PA Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

PA Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$573K Buy
+38,887
New +$563K 0.4% 95

Other funds holding AUPH

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

PA Capital's AUPH Position: Q3 2020 in Review

PA Capital opened a new position in Aurinia Pharmaceuticals (AUPH) in Q3 2020: 38,887 shares worth $573K. The stake represents 0.4% of the portfolio and ranks #95 among its holdings.

145 funds tracked by Wall St. Rank hold AUPH as of Q3 2020.

  • PA Capital held 38,887 shares of Aurinia Pharmaceuticals worth $573K as of Q3 2020.
  • Aurinia Pharmaceuticals was a new PA Capital position in Q3 2020.
  • Aurinia Pharmaceuticals made up 0.4% of PA Capital's portfolio in Q3 2020, its #95 holding.
  • 145 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2020.

Based on PA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.